ELEVATION ONCOLOGY INC's ticker is ELEV and the CUSIP is 28623U101. A total of 28 filers reported holding ELEVATION ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,930,985 | -56.4% | 2,914,255 | 0.0% | 0.55% | -65.8% |
Q2 2023 | $4,429,668 | +24.9% | 2,914,255 | +56.1% | 1.60% | -18.4% |
Q1 2023 | $3,546,044 | +100.0% | 1,866,339 | 0.0% | 1.96% | +257.3% |
Q4 2022 | $1,773,022 | -15.9% | 1,866,339 | 0.0% | 0.55% | +12.7% |
Q3 2022 | $2,109,000 | -19.3% | 1,866,339 | 0.0% | 0.49% | -34.4% |
Q2 2022 | $2,613,000 | -60.2% | 1,866,339 | -28.4% | 0.74% | -48.9% |
Q1 2022 | $6,573,000 | -58.1% | 2,608,167 | 0.0% | 1.46% | -48.5% |
Q4 2021 | $15,701,000 | -22.7% | 2,608,167 | 0.0% | 2.83% | +39.8% |
Q3 2021 | $20,318,000 | -42.6% | 2,608,167 | 0.0% | 2.02% | -51.5% |
Q2 2021 | $35,393,000 | – | 2,608,167 | – | 4.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Qiming U.S. Ventures Management, LLC | 2,370,142 | $3,602,616 | 3.79% |
Aisling Capital Management LP | 2,834,910 | $4,309,063 | 2.11% |
venBio Partners LLC | 2,914,255 | $4,429,668 | 1.60% |
TANG CAPITAL MANAGEMENT LLC | 4,000,000 | $6,080,000 | 0.90% |
Velan Capital Investment Management LP | 497,299 | $755,894 | 0.70% |
Ikarian Capital, LLC | 1,149,490 | $1,747,225 | 0.28% |
Samsara BioCapital, LLC | 830,565 | $1,262,459 | 0.22% |
SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $1,368,000 | 0.21% |
DAFNA Capital Management LLC | 450,000 | $684,000 | 0.19% |
BVF INC/IL | 2,312,200 | $3,514,544 | 0.10% |